We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BIVI market cap is 19.93M. The company's latest EPS is USD -1.7888 and P/E is -0.60.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.78M | -7.73M | -4.79M | -4.12M | -7.29M |
| Net Income | -8.4M | -8.95M | -4.94M | -4.48M | -7.16M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.69M | -138.05M | -27.25M | -45.08M | -32.18M |
| Net Income | -33.78M | -183.85M | -26.08M | -50.26M | -33.01M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.49M | 31.77M | 25.21M | 21.24M | 25.69M |
| Total Liabilities | 14M | 12.85M | 9.7M | 7.17M | 1.77M |
| Total Equity | 7.49M | 18.93M | 15.51M | 14.07M | 23.92M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.08M | 6.05M | 20.12M | 35.11M | 25.21M |
| Total Liabilities | 23.58M | 996k | 16.44M | 19.77M | 9.7M |
| Total Equity | -21.5M | 5.05M | 3.67M | 15.34M | 15.51M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.09M | -23.94M | -27.95M | -3.58M | -12.16M |
| Investing | 14.53M | 14.53M | 14.53M | N/A | N/A |
| Financing | 4.33M | 20.3M | 17.8M | -241k | 12.73M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.63M | -10.45M | -18.99M | -40.25M | -27.95M |
| Investing | N/A | N/A | N/A | -14.3M | 14.53M |
| Financing | 1.33M | 14.93M | 33.12M | 55.37M | 17.8M |
| Market Cap | 19.93M |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.83 |
| Price to Book Ratio | 1.27 |
| Dividend Yield | - |
| Shares Outstanding | 18.45M |
| Average Volume (1 week) | 237.31k |
| Average Volume (1 Month) | 295.91k |
| 52 Week Change | -84.35% |
| 52 Week High | 7.50 |
| 52 Week Low | 0.985 |
| Spread (Intraday) | 0.08 (7.41%) |
| Company Name | BioVie Inc |
| Address |
701 s. carson street carson city, nevada 89701 |
| Website | https://www.bioviepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
